anthranilamide has been researched along with Blood Clot in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Huang, C; Li, Y; Meng, F; Wang, W; Xu, W; Yuan, J; Zhang, S | 1 |
| Fu, X; Huang, C; Meng, F; Wang, W; Xu, W; Xu, Y; Yuan, J; Zhang, S | 1 |
| Chang, CH; Cheney, DL; Corte, JR; Fang, T; Gauuan, JF; Hadden, M; Han, W; He, K; Hu, Z; Jiang, XJ; Knabb, RM; Lam, PY; Li, YL; Luettgen, JM; Morin, PE; Orton, D; Pinto, DJ; Rendina, AR; Wexler, RR; Wong, PC | 1 |
3 other study(ies) available for anthranilamide and Blood Clot
| Article | Year |
|---|---|
Synthesis and evaluation of anthranilamide-based derivatives as FXa inhibitors.
Topics: Adult; Anticoagulants; Blood Coagulation; Computational Biology; Factor Xa; Factor Xa Inhibitors; Humans; Male; Models, Molecular; Molecular Targeted Therapy; ortho-Aminobenzoates; Plasma; Rivaroxaban; Thrombin; Thrombosis | 2017 |
Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.
Topics: Anticoagulants; Blood Coagulation; Crystallography, X-Ray; Drug Design; Factor Xa; Factor Xa Inhibitors; Humans; Models, Molecular; Molecular Docking Simulation; ortho-Aminobenzoates; Rivaroxaban; Structure-Activity Relationship; Thrombin; Thrombosis | 2016 |
Structure-activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties.
Topics: Administration, Oral; Animals; Antithrombin III; Arteriovenous Shunt, Surgical; Binding Sites; Biological Availability; Models, Animal; ortho-Aminobenzoates; Piperidines; Pyridones; Rabbits; Serine Proteinase Inhibitors; Structure-Activity Relationship; Thrombosis | 2008 |